512 results on '"Townend, Jonathan N"'
Search Results
152. SUCCESSFUL TREATMENT OF SEVERE PORTOPULMONARY HYPERTENSION AFTER LIVER TRANSPLANTATION BY BOSENTAN
153. Nitric Oxide and Cardiac Muscarinic Control in Humans
154. The prognostic significance of short-term measurements of heart rate variability assessed early following acute myocardial infarction
155. Experimental exposure to carbon particles does not cause adverse changes in cardiac autonomic control or a systemic inflammatory response in human subjects
156. Cardiac vagal response to water ingestion in normal human subjects
157. Nitric oxide and cardiac parasympathetic control in human heart failure
158. l-Arginine Augments Cardiac Vagal Control in Healthy Human Subjects
159. The elective use of the seven‐cell NIR stent in coronary arteries < 2.75 mm in diameter: Clinical and angiographic results at 6‐month follow‐up
160. A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease
161. Upregulation of the Nitric Oxide-cGMP Pathway in Aged Myocardium
162. Vitamin E supplementation
163. Nitric Oxide and Cardiac Autonomic Control in Humans
164. Use of opposing reflex stimuli and heart rate variability to examine the effects of lipophilic and hydrophilic β-blockers on human cardiac vagal control
165. Role of nitric oxide in the regulation of cardiovascular autonomic control
166. Validation of the conductance catheter method for measurement of ventricular volumes under varying conditions relevant to cardiac surgery
167. A central γ-aminobutyric acid mechanism in cardiac vagal control in man revealed by studies with intravenous midazolam
168. A Longitudinal Study of Mitral Regurgitation Detected after Acute Myocardial Infarction.
169. Sleep and blood pressure: spontaneous baroreflex sensitivity in dippers and non-dippers
170. Modulation of Cardiac Autonomic Control in Humans by Angiotensin II
171. Coronary Artery Calcium Assessment in CKD: Utility in Cardiovascular Disease Risk Assessment and Treatment?
172. Fatal pulmonary venoocclusive disease after use of oral contraceptives
173. Does immunosuppressant medication lower blood pressure and arterial stiffness in patients with chronic kidney disease? An observational study.
174. Effects of nitroglycerin treatment on cardiac autonomic control in heart failure.
175. A population cohort analysis of English transplant centers indicates major adverse cardiovascular events after kidney transplantation.
176. Atrial Fibrillation in CKD: Balancing the Risks and Benefits of Anticoagulation
177. Defining the Natural History of Uremic Cardiomyopathy in Chronic Kidney Disease The Role of Cardiovascular Magnetic Resonance
178. Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease A Randomized Controlled Trial
179. Prognostic Utility of Calcium Scoring as an Adjunct to Stress Myocardial Perfusion Scintigraphy in End-Stage Renal Disease
180. Coronary Atherosclerotic Plaque Activity and Risk of Myocardial Infarction.
181. Prevalence and Impact of Concomitant Atrial Fibrillation in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction.
182. Double-stenting of an ostial left main-stem lesion for elastic recoil
183. Impaired circumferential and longitudinal myocardial deformation in early stage chronic kidney disease: the earliest features of uremic cardiomyopathy.
184. Comparison of magnetic resonance feature tracking for longitudinal strain calculation with spatial modulation of magnetization imaging analysis.
185. Management of heart failure in patients with kidney disease—updates from the 2021 ESC guidelines.
186. Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype.
187. Reducing mortality in myocardial infarction
188. The EARNEST Study: Interarm blood pressure differences should also be recorded.
189. The EARNEST study: interarm blood pressure differences should also be recorded.
190. The OPTIMMAL trial: losartan or captopril after acute myocardial infarction.
191. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial.
192. Invite all donors to participate in follow-up studies
193. Phosphate: are we squandering a scarce commodity?
194. Screening for occult coronary artery disease in potential kidney transplant recipients: time for reappraisal?
195. Acute kidney injury is more common in men than women after accounting for socioeconomic status, ethnicity, alcohol intake and smoking history.
196. Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
197. Coronary flow velocity reserve and inflammatory markers in living kidney donors.
198. Macrophage infiltrates in coronary plaque erosion and cardiovascular outcome in patients with acute coronary syndrome.
199. Assessing flow limitation in patients with stable coronary artery disease
200. Prognostic Utility of Calcium Scoring as an Adjunct to Stress Myocardial Perfusion Scintigraphy in End-Stage Renal Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.